Organized by DIA and CoRE
Scientific breakthroughs, growing amounts of healthcare data and globalization hold great promises for better health outcomes for patients in need.
Data analytics, real-world evidence, remote clinical monitoring, connected health records, electronic labeling and mobile health apps are among some of the trending topics that will shape the healthcare landscape in the coming years.
Alongside the advances in scientific understanding and health product development overall, paradigm shifts in regulatory processes and global convergence are important for greater synergy among all to bring forth timely innovation benefits to patients and consumers and patients that will improve health outcomes.
Who should attend?
- Industry professionals involved in Research & Development, Regulatory Affairs and Medical Affairs in Pharmaceuticals and Medical Technology
- Regulators and personnel from Health Authorities and Ministries
- Academia and Researchers
Dorothee Grimald, PharmD • Director, Global Regulatory Policy
MSD Singapore, Singapore
James Leong, PhD, MPharm • Head of Pharmaceutical Regulatory Science Programme
Duke NUS, Singapore
Finny Liu, MSc, RPh • APAC Regional Regulatory Policy Lead
Roche Singapore Pte Ltd, Singapore
Mei Ding • JAPAC Regional Lead, Policy & Intelligence
Abbvie Pte. Ltd., Singapore
Khairul Faizi Khalid, MD • Head of Business Development
Clinical Research Malaysia, Malaysia
Thean Soo Lo •
Regulatory Affairs Management Consultant, Singapore
Shun Jin, MBA • Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
Jing Ping Yeo, PhD • Director, Research Integrity, Compliance and Ethics
Kum Cheun Wong, PharmD • Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
Lars Nelleman, MD, MPharm • Founder and Owner
Lars Nelleman Consulting, Singapore
Vicky (Fengyun) Han • Senior Director, Asia Pacific Regulatory Policy Group Lead, Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore